Atorvastatin Inhibits High-Fat Diet-Induced Lipid Metabolism Disorders in Rats by Inhibiting Bacteroides Reduction and Improving Metabolism

References

• Hedayatnia M, Asadi Z, Zare-Feyzabadi R, et al. Dyslipidemia and cardiovascular disease risk among the MASHAD study population. Lipids Health Dis. 2020;19(1):42. doi:10.1186/s12944-020-01204-y
   Web of Science ®Google Scholar
• Carlin JL, Grissom N, Ying Z, et al. Voluntary exercise blocks Western diet-induced gene expression of the chemokines CXCL10 and CCL2 in the prefrontal cortex. Brain Behav Immun. 2016;58:82–90. doi:10.1016/j.bbi.2016.07.161
   PubMed Web of Science ®Google Scholar
• Lapergue B, Mohammad A, Shuaib A. Endothelial progenitor cells and cerebrovascular diseases. Prog Neurobiol. 2007;83(6):349–362. doi:10.1016/j.pneurobio.2007.08.001
   Web of Science ®Google Scholar
• Henk HJ, Paoli CJ, Gandra SR. A retrospective study to examine healthcare costs related to cardiovascular events in individuals with hyperlipidemia. Adv Ther. 2015;32(11):1104–1116. doi:10.1007/s12325-015-0264-7
   Web of Science ®Google Scholar
• An HJ, Kim JY, Gwon MG, et al. Beneficial effects of SREBP decoy oligodeoxynucleotide in an animal model of hyperlipidemia. Int J Mol Sci. 2020;21(2):552. doi:10.3390/ijms21020552
   Web of Science ®Google Scholar
• Umeda R, Takanari H, Ogata K, et al. Direct free radical scavenging effects of water-soluble HMG-CoA reductase inhibitors. J Clin Biochem Nutr. 2019;64(1):20–26. doi:10.3164/jcbn.18-48
   Web of Science ®Google Scholar
• Okada Y, Yamaguchi K, Nakajima T, et al. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats. Liver Int. 2013;33(2):301–311. doi:10.1111/liv.12033
   PubMed Web of Science ®Google Scholar
• Tavares TB, Santos IB, de Bem GF, et al. Therapeutic effects of açaí seed extract on hepatic steatosis in high-fat diet-induced obesity in male mice: a comparative effect with rosuvastatin. J Pharm Pharmacol. 2020;72(12):1921–1932. doi:10.1111/jphp.13356
   Web of Science ®Google Scholar
• Khan TJ, Ahmed YM, Zamzami MA, et al. Effect of atorvastatin on the gut microbiota of high fat diet-induced hypercholesterolemic rats. Sci Rep. 2018;8(1):662. doi:10.1038/s41598-017-19013-2
   PubMed Web of Science ®Google Scholar
• Sharma M, Mehta I. Surface stabilized atorvastatin nanocrystals with improved bioavailability, safety and antihyperlipidemic potential. Sci Rep. 2019;9(1):16105. doi:10.1038/s41598-019-52645-0
   PubMed Web of Science ®Google Scholar
• Daniel H, Gholami AM, Berry D, et al. High-fat diet alters gut microbiota physiology in mice. ISME J. 2014;8(2):295–308. doi:10.1038/ismej.2013.155
   PubMed Web of Science ®Google Scholar
• Zhu L, Zhang D, Zhu H, et al. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe(-/-) mice. Atherosclerosis. 2018;268:117–126. doi:10.1016/j.atherosclerosis.2017.11.023
   PubMed Web of Science ®Google Scholar
• Araújo JR, Tomas J, Brenner C, et al. Impact of high-fat diet on the intestinal microbiota and small intestinal physiology before and after the onset of obesity. Biochimie. 2017;141:97–106. doi:10.1016/j.biochi.2017.05.019
   PubMed Web of Science ®Google Scholar
• Khan TJ, Ahmed YM, Zamzami MA, et al. Atorvastatin treatment modulates the gut microbiota of the hypercholesterolemic patients. OMICS. 2018;22(2):154–163. doi:10.1089/omi.2017.0130
   PubMed Web of Science ®Google Scholar
• Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20(4):461–472. doi:10.1007/s11154-019-09512-0
   PubMed Web of Science ®Google Scholar
• Gerard P, Lepercq P, Leclerc M, et al. Bacteroides sp. Strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl Environ Microbiol. 2007;73(18):5742–5749. doi:10.1128/AEM.02806-06
   PubMed Web of Science ®Google Scholar
• Wahlström A, Sayin SI, Marschall H-U, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47(2):241–259. doi:10.1194/jlr.R500013-JLR200
   PubMed Web of Science ®Google Scholar
• Kim J, Lee H, An J, et al. Alterations in gut microbiota by statin therapy and possible intermediate effects on hyperglycemia and hyperlipidemia. Front Microbiol. 2019;10:1947. doi:10.3389/fmicb.2019.01947
   PubMed Web of Science ®Google Scholar
• Wan Y, Wang FL, Yuan JH, et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut. 2019;68(8):1417–1429. doi:10.1136/gutjnl-2018-317609
   PubMed Web of Science ®Google Scholar
• Xu Y, Han J, Dong J, et al. Metabolomics characterizes the effects and mechanisms of quercetin in nonalcoholic fatty liver disease development. Int J Mol Sci. 2019;20(5):1220. doi:10.3390/ijms20051220
   PubMed Web of Science ®Google Scholar
• Beger RD, Dunn W, Schmidt MA, et al. Metabolomics enables precision medicine: “A White Paper, Community Perspective”. Metabolomics. 2016;12(10):149. doi:10.1007/s11306-016-1094-6
   PubMed Web of Science ®Google Scholar
• Chen HH, Tseng YJ, Wang SY, et al. The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity. Int J Obes. 2015;39(8):1241–1248. doi:10.1038/ijo.2015.65
   Web of Science ®Google Scholar
• Ding Y, Svingen GF, Pedersen ER, et al. Plasma glycine and risk of acute myocardial infarction in patients with suspected stable angina pectoris. J Am Heart Assoc. 2015;5(1):e002621. doi:10.1161/JAHA.115.002621
   PubMed Web of Science ®Google Scholar
• Han JS, Kim K, Jung Y, et al. Metabolic alterations associated with atorvastatin/fenofibric acid combination in patients with atherogenic dyslipidaemia: a randomized trial for comparison with escalated-dose atorvastatin. Sci Rep. 2018;8(1):14642. doi:10.1038/s41598-018-33058-x
   Web of Science ®Google Scholar
• Bokulich NA, Subramanian S, Faith JJ, et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat Methods. 2013;10(1):57–59. doi:10.1038/nmeth.2276
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336. doi:10.1038/nmeth.f.303
   PubMed Web of Science ®Google Scholar
• Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494–504. doi:10.1101/gr.112730.110
   PubMed Web of Science ®Google Scholar
• Edgar RC, Haas BJ, Clemente JC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27(16):2194–2200. doi:10.1093/bioinformatics/btr381
   PubMed Web of Science ®Google Scholar
• Edgar RC. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013;10(10):996–998. doi:10.1038/nmeth.2604
   PubMed Web of Science ®Google Scholar
• Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41:D590–D596. doi:10.1093/nar/gks1219
   PubMed Web of Science ®Google Scholar
• Luo P, Dai W, Yin P, et al. Multiple reaction monitoring-ion pair finder: a systematic approach to transform nontargeted mode to pseudotargeted mode for metabolomics study based on liquid chromatography-mass spectrometry. Anal Chem. 2015;87(10):5050–5055. doi:10.1021/acs.analchem.5b00615
   Web of Science ®Google Scholar
• Gao Y, Zhang W, Zeng LQ, et al. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol. 2020;36:101635. doi:10.1016/j.redox.2020.101635
   PubMed Web of Science ®Google Scholar
• Frost F, Storck LJ, Kacprowski T, et al. A structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: a pilot study. PLoS One. 2019;14(7):e0219489. doi:10.1371/journal.pone.0219489
   PubMed Web of Science ®Google Scholar
• Astbury S, Atallah E, Vijay A, et al. Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes. 2020;11(3):569–580. doi:10.1080/19490976.2019.1681861
   PubMed Web of Science ®Google Scholar
• Gomez-Arango LF, Barrett HL, Wilkinson SA, et al. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women. Gut Microbes. 2018;9(3):189–201. doi:10.1080/19490976.2017.1406584
   PubMed Web of Science ®Google Scholar
• Richards JL, Yap YA, McLeod KH, et al. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunol. 2016;5(5):e82. doi:10.1038/cti.2016.29
   Web of Science ®Google Scholar
• Zhou LY, Xiao XH, Li M, et al. Maternal exercise improves high-fat diet-induced metabolic abnormalities and gut microbiota profiles in mouse dams and offspring. Front Cell Infect Microbiol. 2020;10:292. doi:10.3389/fcimb.2020.00292
   Web of Science ®Google Scholar
• Liu J, Yue S, Yang Z, et al. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. Pharmacol Res. 2018;134:40–50. doi:10.1016/j.phrs.2018.05.012
   PubMed Web of Science ®Google Scholar
• Taalberg E, Kilk K. Mapping metabolite and ICD-10 associations. Metabolites. 2020;10(5):196. doi:10.3390/metabo10050196
   Web of Science ®Google Scholar
• Grimaldi M, Palisi A, Marino C, et al. NMR-based metabolomic profile of hypercholesterolemic human sera: relationship with in vitro gene expression? PLoS One. 2020;15(4):e0231506. doi:10.1371/journal.pone.0231506
   Web of Science ®Google Scholar
• Zhuang T, Liu X, Wang W, et al. Dose-related urinary metabolic alterations of a combination of quercetin and resveratrol-treated high-fat diet fed rats. Front Pharmacol. 2021;12:655563. doi:10.3389/fphar.2021.655563
   Web of Science ®Google Scholar
• Wang J, Wu Z, Li D, et al. Nutrition, epigenetics, and metabolic syndrome. Antioxid Redox Signal. 2012;17(2):282–301. doi:10.1089/ars.2011.4381
   PubMed Web of Science ®Google Scholar
• Cojocaru E, Magdalena Leon-Constantin M, Ungureanu C, et al. Hypolipemiant actions and possible cardioprotective effects of valine and leucine: an experimental study. Medicina. 2021;57(3):239. doi:10.3390/medicina57030239
   Web of Science ®Google Scholar
• O’Connor K, Morrissette M, Strandwitz P, et al. Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model. PLoS One. 2019;14(11):e0224836. doi:10.1371/journal.pone.0224836
   PubMed Web of Science ®Google Scholar
• Han J, Zhang R, Muheyati D, et al. The effect of chickpea dietary fiber on lipid metabolism and gut microbiota in high-fat diet-induced hyperlipidemia in rats. J Med Food. 2021;24(2):124–134. doi:10.1089/jmf.2020.4800
   Web of Science ®Google Scholar
• Sears CL. A dynamic partnership: celebrating our gut flora. Anaerobe. 2005;11(5):247–251. doi:10.1016/j.anaerobe.2005.05.001
   PubMed Web of Science ®Google Scholar
• Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20(4):593–621. doi:10.1128/CMR.00008-07
   PubMed Web of Science ®Google Scholar
• Zhang X, Coker OO, Chu ES, et al. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut. 2021;70(4):761–774. doi:10.1136/gutjnl-2019-319664
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhao S, Yan W, et al. Branched chain amino acids cause liver injury in obese/diabetic mice by promoting adipocyte lipolysis and inhibiting hepatic autophagy. EBioMedicine. 2016;13:157–167. doi:10.1016/j.ebiom.2016.10.013
   PubMed Web of Science ®Google Scholar
• Takegoshi K, Honda M, Okada H, et al. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model. Oncotarget. 2017;8(11):18191–18205. doi:10.18632/oncotarget.15304
   Google Scholar